Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Genomic and Epigenomic Signatures Can Distinguish Aggressive Chromophobe Renal Cell Carcinoma from Indolent Renal Oncocytic Tumors in Clinical-grade Samples

European Urology Oncology(2025)10.1016/j.euo.2025.09.018Source: DataRank Database

Genomic and Epigenomic Signatures Can Distinguish Aggressive Chromophobe Renal Cell Carcinoma from Indolent Renal Oncocytic Tumors in Clinical-grade Samples is a research paper published in European Urology Oncology (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.00)OA: closedTopics (44)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (23)

Qi Wang ORCID,Gayatri Kumar ORCID,Mahmut Akgül ORCID,Chad J. Creighton ORCID,Priya Rao ORCID

Live enrichment

PubMed:41193273 OpenAlex:https://openalex.org/W4415901316

National Institutes of Health

Grant: CA125123

NCI NIH HHS

Grant: P30 CA016672

NCI NIH HHS

Grant: P30 CA125123

University of Texas MD Anderson Cancer Center

FWCI

0.00

Citation Percentile

0.4%

closedLicense: http://www.elsevier.com/open-access/userlicense/1.0/

publisherhttps://api.elsevier.com/content/article/PII:S2588931125002810?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2588931125002810?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.euo.2025.09.018

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41193273

Fields of Study

Renal cell carcinoma treatmentGenetic and Kidney Cyst DiseasesPancreatic and Hepatic Oncology ResearchHumansCarcinoma, Renal CellKidney NeoplasmsAdenoma, OxyphilicMaleFemaleMiddle AgedEpigenomicsAgedGenomicsDNA MethylationGene Expression ProfilingDiagnosis, DifferentialAdultNeoplasm GradingOncocytoma, renal

MeSH Terms

AdultAgedCarcinoma, Renal CellDiagnosis, DifferentialFemaleHumansKidney NeoplasmsMaleMiddle AgedAdenoma, OxyphilicDNA MethylationGene Expression ProfilingGenomicsEpigenomicsNeoplasm Grading

Keywords

EpigenomicsRenal cell carcinomaChromophobe cellRenal oncocytomaClear cellOncocytomaMutationMethylationGene ExpressionChromophobe Renal Cell Carcinoma

Genomic and Epigenomic Signatures Can Distinguish Aggressive Chromophobe Renal Cell Carcinoma from Indolent Renal Oncocytic Tumors in Clinical-grade Samples

FAIR Checklist

Authors (23)

Funding (4 grants)

Impact

Open Access

Topics